<p>Jefferies 分析师 Jack Slevin 今天对 Cross Country Healthcare 维持了持有评级，并设定了 8.65 美元的目标价。</p>
<h3>TipRanks 网络星期一促销</h3>
<ul>
<li>享受 TipRanks Premium 60% 的折扣，获取数据支持的洞察和研究工具，让您自信投资。</li>
<li>订阅 TipRanks 的智能投资者精选，通过我们高表现的模型投资组合查看我们的数据 - 现在也享受 60% 的折扣。</li>
</ul>
<p>Jack Slevin 给予持有评级是基于围绕 Cross Country Healthcare 最近发展的多种因素。Aya 提议的收购终止使 CCRN 收到了 2000 万美元的终止费，他们计划将其用于立即回购股票。这一战略举措得到了他们强劲的净现金状况的支持，扣除解约费后，净现金约为 1.15 亿美元。</p>
<p>尽管在收购干扰消除后，基本面有适度恢复的潜力，但公司的当前财务轨迹仍然不确定。交易终止后缺乏第四季度指导增加了短期风险，促使采取谨慎态度。因此，Slevin 将目标价调整为 8.65 美元，反映出由于这些不确定性而略低的估值，同时维持持有评级，等待更具体的基本面改善迹象。</p>

Cross Country医疗保健

<p>Jefferies 分析师 Jack Slevin 对 Cross Country Healthcare 维持了持有评级，目标价为 8.65 美元。Aya 提议收购的终止导致了 2000 万美元的终止费，CCRN 计划将其用于股票回购。尽管公司拥有强劲的净现金状况，但其财务轨迹仍然不确定，缺乏第四季度的指导。Slevin 的谨慎态度反映了这些不确定性，正在等待基本面改善的迹象</p>

<p>Jefferies analyst Jack Slevin maintained a Hold rating on Cross Country Healthcare today and set a price target of $8.65.</p>
<div class="lb-trans"><p>Jefferies 分析师 Jack Slevin 今天对 Cross Country Healthcare 维持了持有评级，并设定了 8.65 美元的目标价。</p>
</div><h3>TipRanks Cyber Monday Sale</h3>
<div class="lb-trans"><h3>TipRanks 网络星期一促销</h3>
</div><ul>
<li>Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.</li>
<li>Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio -  now also 60% off</li>
</ul>
<div class="lb-trans"><ul>
<li>享受 TipRanks Premium 60% 的折扣，获取数据支持的洞察和研究工具，让您自信投资。</li>
<li>订阅 TipRanks 的智能投资者精选，通过我们高表现的模型投资组合查看我们的数据 - 现在也享受 60% 的折扣。</li>
</ul>
</div><p>Jack Slevin has given his Hold rating due to a combination of factors surrounding Cross Country Healthcare’s recent developments. The termination of the proposed acquisition by Aya has resulted in CCRN receiving a $20 million termination fee, which they plan to use for immediate share buybacks. This strategic move is supported by their strong net cash position, which stands at approximately $115 million after accounting for the breakup fee.</p>
<div class="lb-trans"><p>Jack Slevin 给予持有评级是基于围绕 Cross Country Healthcare 最近发展的多种因素。Aya 提议的收购终止使 CCRN 收到了 2000 万美元的终止费，他们计划将其用于立即回购股票。这一战略举措得到了他们强劲的净现金状况的支持，扣除解约费后，净现金约为 1.15 亿美元。</p>
</div><p>Despite the potential for a modest recovery in fundamentals now that the acquisition distraction is removed, the company’s current financial trajectory remains uncertain. The lack of fourth-quarter guidance following the deal termination adds to the near-term risk, prompting a cautious stance. Consequently, Slevin adjusted the price target to $8.65, reflecting a slightly lower valuation due to these uncertainties, while maintaining a Hold rating as they await more concrete signs of fundamental improvement.</p>
<div class="lb-trans"><p>尽管在收购干扰消除后，基本面有适度恢复的潜力，但公司的当前财务轨迹仍然不确定。交易终止后缺乏第四季度指导增加了短期风险，促使采取谨慎态度。因此，Slevin 将目标价调整为 8.65 美元，反映出由于这些不确定性而略低的估值，同时维持持有评级，等待更具体的基本面改善迹象。</p>
</div>

Cross Country 医疗保健：因收购终止及财务前景不明，维持持有评级